A ‘molecular’ look at prostate canc… – Information Centre – Research & Innovation

Procedure guidance for prostate cancer sufferers is not optimal mainly because existing clinical exams do not obviously differentiate between gradual-escalating and intense forms. An EU-funded venture is addressing this by researching the underlying molecular mechanisms of the disorder to empower personalised and helpful therapy.